CLINICAL_TRIALS
trial_result
· 2025-08-12
Clinical Trial Update: First in Human Study of ChAdOx1-HBV in Healthy Participants and Participants With Chronic hepB Infection [Phase 1]
Summary
First-in-human Phase 1 study of the ChAdOx1-HBV vaccine in healthy individuals and patients with chronic hepatitis B; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Barinthus Biotherapeutics | Conditions: Hepatitis B, Healthy | Phase 1 | Status: COMPLETED | Results posted: 2025-08-12